February 6, 2020   FDA Approves Drug for Adult Insomnia The U.S. Food and Drug Administration (FDA) has approved lemborexant (DAYVIGO™) for the treatment of adult insomnia. The dosage will be prescribed in 5 mg and 10 mg tabs for patients who struggle with sleep onset or staying asleep. (Image: ©Shutterstock) ADVERTISEMENT Have We Entered the Age of the Immoronic? "As an ethicist and physician, I have been struggling to come up with a term that summarizes the potent combination of ignorance and immorality that characterizes certain elements in American society today." (Image: ©Adobe)